Home Press office Press releases information releases Press releases Archives Prizes and awards Press releases May 13, 2015 Invitation to the conference "Clinical trials - a new opening" April 9, 2015 "Is there a place for a mission in the group?" - interview with the General Director of Amgen Polska, Marcin Hańczaruk April 8, 2015 Amgen celebrates its 35th anniversary April 6, 2015 European commission approves Vectibix® (panitumumab) in combination with FOLFIRI chemotherapy to fight advanced colorectal cancer March 27, 2015 Amgen supports the Festival of Young Researchers March 22, 2015 A competition that opens the head. Interview with Maria Mach, director of the office of the National Children's Fund March 1, 2015 The results of the ENDEAVOR study confirm the effectiveness of Kyprolis® in the treatment of multiple myeloma January 20, 2015 Amgen won the Quality of the Year 2014 award in the innovation category November 12, 2014 The new edition of the Amgen Scholars program is starting October 16, 2014 Amgen is committed to research on the Ebola virus September 9, 2014 A revolution in the treatment of acute lymphoblastic leukemia - blinatumomab becomes a breakthrough therapy September 1, 2014 Patients suffering from osteoporosis will receive effective and modern treatment. The biological drug Prolia ® is now 70% refunded. August 21, 2014 Notice to healthcare professionals about Prolia ® (Denosumab 60 mg) August 21, 2014 Communication to health professionals concerning the medicinal product Xgeva ® (Denosumab 120 mg) August 19, 2014 Fundacja Amgen wsparła nauczycieli przedmiotów przyrodniczych z Europy kwotą 2 milionów euro 4 sierpnia 2014 Osiągnięto cel pierwszorzędowy w fazie III badania klinicznego ASPIRE, w którym testowano lek Kyprolis® u pacjentów z opornym nawrotowym szpiczakiem mnogim © Amgen Inc 2011. All rights reserved. Privacy Policy | Contact | Site Map | Legal Disclaimer | Terms of Use | Amgen | Our Products | Career in Amgen | Amgen Scholars | Socially Responsible Company | Biotechnology Company | Aranesp | Mimpara | Neulasta | Neupogen | Nplate | Prolia | Vectibix | XGEVA | Prolia.pl